close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Tickers BEAT
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
Disrupting the Pharmacy: A Deep-Dive into Hims & Hers Health (HIMS) in 2026
Via Finterra
Topics Artificial Intelligence Economy
Tickers AMZN C CVS HIMS NVO UBER
Exposures Artificial Intelligence Product Safety Supply Chain
News headline image
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026
Via NewMediaWire
Topics Lawsuit
Tickers SLNO
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers SLNO
Exposures Financial Legal Product Safety
News headline image
uniQure Shares Surge 26% On US FDA Shakeup Even As Momentum Tumbles: Will New Leadership Greenlight Huntington's Therapy? ↗
Via Benzinga
Exposures Product Safety
News headline image
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
Via Stocktwits
Topics Initial Public Offering
Tickers IBB LABU QURE XBI
Exposures Product Safety Securities Market
News headline image
Global Clean Beauty Market Expands with 9.98% CAGR Through 2031 Driven by Transparency and Sustainable Formulations
Via Press Release Distribution Service
Tickers AMZN
Exposures Product Safety
News headline image
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
HIMS Stock Rockets To Best Day Ever After Novo Nordisk Pact — Wall Street Upgrades Roll In As Shorts Lose $546M In One Day ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
Tickers C HIMS NVO
Exposures Financial Intellectual Property Legal
News headline image
Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026
Via NewMediaWire
Topics Lawsuit
Tickers SLNO
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers SLNO
Exposures Financial Legal Product Safety
News headline image
Paul Arrendell Calls for a “Systems First” Standard in Everyday Work
Via Get News
Topics Product Recall
Tickers ASAN
Exposures Legal Product Safety
News headline image
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
TRVI Stock Slips After Company Plans Parallel Trials In Lung Disease — Stifel Dismisses Timeline Concerns ↗
Via Stocktwits
Tickers IWM TRVI VXF
Exposures Product Safety
News headline image
Axsome Therapeutics CEO Completes Planned $6 Million Options Sale Ahead of Pivotal FDA Decision ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers AXSM
Exposures Legal Product Safety Regulatory
News headline image
Tesla VP Of Finance, Engineer Who Developed OTA Feature Announce Exit Amid Other High-Profile Departures ↗
Via Stocktwits
Topics Product Recall
Tickers TSLA VOO VTI
Exposures Legal Product Safety
News headline image
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy? ↗
Via The Motley Fool
Topics Lawsuit
Tickers HIMS NVO
Exposures Financial Legal Product Safety
News headline image
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
Via Stocktwits
Tickers IBB QURE RY SBIO TSX:RY WFC
Exposures Product Safety
News headline image
ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
QURE DEADLINE: Investors of uniQure N.V. (QURE) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on April 13, 2026
Via NewMediaWire
Topics Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
QURE DEADLINE: Investors of uniQure N.V. (QURE) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on April 13, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
New Year, Same Ford Problem: But Investors Shouldn't Panic ↗
Via The Motley Fool
Topics Product Recall
Tickers F
Exposures Legal Product Safety
News headline image
The Pivot to Legitimacy: Hims & Hers Health (HIMS) Faces a New Era of Personalized Medicine
Via Finterra
Topics Artificial Intelligence Economy
Tickers AMZN HIMS LLY
Exposures Artificial Intelligence Product Safety Supply Chain
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
News headline image
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy ↗
Via Stocktwits
Topics Intellectual Property Lawsuit
Tickers AVDE HIMS NVO PPH PVAL
Exposures Financial Intellectual Property Legal
News headline image
IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data ↗
Via Stocktwits
Tickers IBRX IWM VB XBI
Exposures Product Safety
News headline image
OS Therapies Announces FDA OST-HER2 Type D Meeting Elevated to Type B Pre-BLA Meeting
Via Newsfile
Topics Intellectual Property
Tickers OSTX
Exposures Intellectual Property Product Safety
News headline image
Can IBRX Stock Snap Its 4-Day Slide? Founder Promises ‘Game-Changer’ Anktiva Data As FDA Speeds Drug Reviews ↗
Via Stocktwits
Tickers IBRX
Exposures Product Safety
News headline image
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today